Status:
UNKNOWN
The Effects of a Single Dose of Methylphenidate on Motor Performance
Lead Sponsor:
Loewenstein Hospital
Collaborating Sponsors:
Tel Aviv University
Wingate Institute
Conditions:
ADHD
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
Aim: To evaluate the effects of MPH on young adults diagnosed with ADHD on different exercise performance tests. Hypothesis: MPH will have positive effects on motor tests requiring concentration. Me...
Detailed Description
200 healthy physical education students and Mechina from the Academic College at Wingate, males and females, will be recruited to the study. 100 participants diagnosed with ADHD will serve as the trea...
Eligibility Criteria
Inclusion
- Students age 18-45 years old studying at the academic college at Wingate. For the treatment group we will recruit students who were previously diagnosed by a neurologist or psychiatrist or other ADHD physician specialist as having ADHD, and are treated with a methylphenidate (Ritalin; Ritalin SR; Ritalin LA; Concerta) at least 3 months before the first session. Control group will consist of students without ADHD.
Exclusion
- any chronic illness other than ADHD (e.g. asthma, gastrointestinal, depression, anxiety, etc.), taking chronic medications apart from stimulant therapy.
Key Trial Info
Start Date :
May 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04283604
Start Date
May 27 2021
End Date
March 1 2024
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sharon Tsuk
Netanya, Israel, 42902